Amrutanjan Healthcare

BSE : 590006 | NSE : AMRUTANJAN
Industry : Pharma Formulations | ISIN : INE098F01031 | FreeFloat : 50.00% | FnO : No | LotSize : N/A
Intellectual Capital (IC)422.88
Net Worth (NW)210.31
Intrinsic Worth (IW)633.20
Market Cap (MC)1,467.82
Economic Value Added13.44
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)66.79%
IC Gross Margin (EBITDA/IC)15.11%
IC Net Margin (NPT/IC)11.02%
Knowledge Turnover (Sales/IC)0.70
Market to Intrinsic Value (MC/IW)2.32
As OfIntrinsic ValueMarket Price
31 Dec 2020Rs. 216.62Rs. 502.15
12 May 2021 - Rs. 666.30
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 637.55BuyStrong Buy
KB > 50% : Yes50 DMA : Rs. 581.10
0 < M2IV < 1 : NoVol-Price trend : Rising

Question 3 - Is this stock undervalued?

Question 2 - Does this business have significant knowledge assets?

Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.
Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Mar-18
S
74.68
75.25
10.77
10.43
10.40
4.99
5.72
Jun-18
S
35.77
37.09
-2.63
-2.03
-2.04
-1.40
-1.54
Sep-18
S
62.05
63.59
8.76
9.49
9.46
6.66
6.49
Dec-18
S
70.27
71.87
6.77
7.56
7.56
5.53
5.29
Mar-19
S
85.97
88.64
18.38
20.23
20.20
14.22
14.27
Jun-19
S
44.60
46.15
-1.56
-0.85
-0.91
-0.70
-0.70
Sep-19
S
74.81
76.67
11.58
12.17
12.12
8.40
8.40
Dec-19
S
82.75
85.01
11.60
12.65
12.60
9.49
9.49
Mar-20
S
59.32
61.96
11.73
10.71
10.64
7.89
7.89
Jun-20
S
46.62
48.66
9.65
8.71
8.66
6.43
6.40
Sep-20
S
92.11
96.16
32.32
31.43
31.39
23.55
23.72
Dec-20
S
100.10
102.64
29.03
28.19
28.14
20.99
20.77
* C - Consolidated, S - Standalone